{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:34:18Z","timestamp":1744173258104,"version":"3.40.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK114477"],"award-info":[{"award-number":["DK114477"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s00774-021-01214-5","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T14:04:50Z","timestamp":1617804290000},"page":"693-699","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A quality improvement project to address the challenges surrounding zoledronic acid use in children"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6895-2372","authenticated-orcid":false,"given":"David R.","family":"Weber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Cristina Gil","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Louis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noya","family":"Rackovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman","family":"Rahmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sierra D.","family":"Stauber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,7]]},"reference":[{"key":"1214_CR1","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s40200-014-0109-y","volume":"13","author":"G Eghbali-Fatourechi","year":"2014","unstructured":"Eghbali-Fatourechi G (2014) Bisphosphonate therapy in pediatric patients. J Diabetes Metab Disord 13:109","journal-title":"J Diabetes Metab Disord"},{"key":"1214_CR2","doi-asserted-by":"publisher","first-page":"4022","DOI":"10.2174\/1381612826666200423092602","volume":"26","author":"Q Fan","year":"2020","unstructured":"Fan Q, Wang J (2020) The efficacy and safety of bisphosphonates for osteoporosis in women older than 65 years: a meta-analysis. Curr Pharm Des 26:4022\u20134030","journal-title":"Curr Pharm Des"},{"key":"1214_CR3","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1002\/jbmr.2567","volume":"30","author":"T Palomo","year":"2015","unstructured":"Palomo T, Fassier F, Ouellet J, Sato A, Montpetit K, Glorieux FH et al (2015) Intravenous bisphosphonate therapy of young children with osteogenesis imperfecta: skeletal findings during follow up throughout the growing years. J Bone Miner Res 30:2150\u20132157","journal-title":"J Bone Miner Res"},{"key":"1214_CR4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/jpc.13768","volume":"54","author":"PJ Simm","year":"2018","unstructured":"Simm PJ, Biggin A, Zacharin MR, Rodda CP, Tham E, Siafarikas A et al (2018) Consensus guidelines on the use of bisphosphonate therapy in children and adolescents. J Paediatr Child Health 54:223\u2013433","journal-title":"J Paediatr Child Health"},{"key":"1214_CR5","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1210\/jc.2010-0636","volume":"96","author":"LM Ward","year":"2011","unstructured":"Ward LM, Rauch F, Whyte MP, D\u2019Astous J, Gates PE, Grogan D et al (2011) Alendronate for the treatment of pediatric osteogenesis imperfecta: a randomized placebo-controlled study. J Clin Endocrinol Metab 96:355\u2013364","journal-title":"J Clin Endocrinol Metab"},{"key":"1214_CR6","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1007\/s00198-016-3528-4","volume":"27","author":"S Trivedi","year":"2016","unstructured":"Trivedi S, Al-Nofal A, Kumar S, Tripathi S, Kahoud RJ, Tebben PJ (2016) Severe non-infective systemic inflammatory response syndrome, shock, and end-organ dysfunction after zoledronic acid administration in a child. Osteoporos Int 27:2379\u20132382","journal-title":"Osteoporos Int"},{"key":"1214_CR7","doi-asserted-by":"publisher","first-page":"4163","DOI":"10.1210\/jc.2015-2680","volume":"100","author":"S George","year":"2015","unstructured":"George S, Weber DR, Kaplan P, Hummel K, Monk HM, Levine MA (2015) Short-term safety of zoledronic acid in young patients with bone disorders: an extensive institutional experience. J Clin Endocrinol Metab 100:4163\u20134171","journal-title":"J Clin Endocrinol Metab"},{"key":"1214_CR8","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s00198-019-05227-9","volume":"31","author":"N Nasomyont","year":"2020","unstructured":"Nasomyont N, Hornung LN, Wasserman H (2020) Intravenous bisphosphonate therapy in children with spinal muscular atrophy. Osteoporos Int 31:995\u20131000","journal-title":"Osteoporos Int"},{"key":"1214_CR9","doi-asserted-by":"publisher","first-page":"256","DOI":"10.21037\/tp.2017.09.10","volume":"6","author":"SA Bowden","year":"2017","unstructured":"Bowden SA, Mahan JD (2017) Zoledronic acid in pediatric metabolic bone disorders. Transl Pediatr 6:256\u2013268","journal-title":"Transl Pediatr"},{"key":"1214_CR10","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3928\/00220124-20151020-02","volume":"46","author":"G Ogrinc","year":"2015","unstructured":"Ogrinc G, Davies L, Goodman D, Batalden P, Davidoff F, Stevens D (2015) SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process. J Contin Educ Nurs 46:501\u2013507","journal-title":"J Contin Educ Nurs"},{"key":"1214_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjquality.u206586.w4692","author":"MWS Ong","year":"2017","unstructured":"Ong MWS, Jones L (2017) Improving bisphosphonate infusion monitoring at haematology medical day unit. BMJ Qual Improv Rep. https:\/\/doi.org\/10.1136\/bmjquality.u206586.w4692","journal-title":"BMJ Qual Improv Rep"},{"key":"1214_CR12","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.bone.2007.05.002","volume":"41","author":"CF Munns","year":"2007","unstructured":"Munns CF, Rajab MH, Hong J, Briody J, H\u00f6gler W, McQuade M, Little DG, Cowell CT (2007) Acute phase response and mineral status following low dose intravenous zoledronic acid in children. Bone 41:366\u2013370","journal-title":"Bone"},{"key":"1214_CR13","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1007\/s00198-012-1911-3","volume":"23","author":"AM Sbrocchi","year":"2012","unstructured":"Sbrocchi AM, Rauch F, Jacob P, McCormick A, McMillan HJ, Matzinger MA et al (2012) The use of intravenous bisphosphonate therapy to treat vertebral fractures due to osteoporosis among boys with Duchenne muscular dystrophy. Osteoporos Int 23:2703\u20132711","journal-title":"Osteoporos Int"},{"key":"1214_CR14","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.bone.2019.01.003","volume":"121","author":"N Nasomyont","year":"2019","unstructured":"Nasomyont N, Hornung LN, Gordon CM, Wasserman H (2019) Outcomes following intravenous bisphosphonate infusion in pediatric patients: a 7-year retrospective chart review. Bone 121:60\u201367","journal-title":"Bone"},{"key":"1214_CR15","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s00198-019-05227-9","volume":"31","author":"N Nasomyont","year":"2019","unstructured":"Nasomyont N, Hornung LN, Wasserman H (2019) Intravenous bisphosphonate therapy in children with spinal muscular atrophy. Osteoporos Int 31:995\u20131000","journal-title":"Osteoporos Int"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-021-01214-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00774-021-01214-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-021-01214-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T02:50:14Z","timestamp":1744167014000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00774-021-01214-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,7]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["1214"],"URL":"https:\/\/doi.org\/10.1007\/s00774-021-01214-5","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"type":"print","value":"0914-8779"},{"type":"electronic","value":"1435-5604"}],"subject":[],"published":{"date-parts":[[2021,4,7]]},"assertion":[{"value":"1 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"David R Weber, Maria Cristina Gil Diaz, Silvia Louis, Noya Rackovsky, Roman Rahmani, and Sierra D Stauber declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}